1. Home
  2. ALBT vs WTO Comparison

ALBT vs WTO Comparison

Compare ALBT & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
    SELLHOLDBUYas of 21 hours ago
  • WTO
    SELLHOLDBUYas of 21 hours ago
  • Stock Information
  • Founded
  • ALBT 2014
  • WTO 2008
  • Country
  • ALBT United States
  • WTO China
  • Employees
  • ALBT N/A
  • WTO N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • WTO Consumer Electronics/Appliances
  • Sector
  • ALBT Health Care
  • WTO Technology
  • Exchange
  • ALBT Nasdaq
  • WTO Nasdaq
  • Market Cap
  • ALBT 7.9M
  • WTO 8.5M
  • IPO Year
  • ALBT N/A
  • WTO 2021
  • Fundamental
  • Price
  • ALBT $4.80
  • WTO $1.42
  • Analyst Decision
  • ALBT
  • WTO
  • Analyst Count
  • ALBT 0
  • WTO 0
  • Target Price
  • ALBT N/A
  • WTO N/A
  • AVG Volume (30 Days)
  • ALBT 83.2K
  • WTO 50.6K
  • Earning Date
  • ALBT 05-30-2025
  • WTO 04-08-2025
  • Dividend Yield
  • ALBT N/A
  • WTO N/A
  • EPS Growth
  • ALBT N/A
  • WTO N/A
  • EPS
  • ALBT N/A
  • WTO N/A
  • Revenue
  • ALBT $486,815.00
  • WTO $32,309,502.00
  • Revenue This Year
  • ALBT N/A
  • WTO N/A
  • Revenue Next Year
  • ALBT N/A
  • WTO N/A
  • P/E Ratio
  • ALBT N/A
  • WTO N/A
  • Revenue Growth
  • ALBT N/A
  • WTO 47.36
  • 52 Week Low
  • ALBT $2.11
  • WTO $1.35
  • 52 Week High
  • ALBT $21.60
  • WTO $622.50
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 43.91
  • WTO 29.67
  • Support Level
  • ALBT $5.18
  • WTO $1.84
  • Resistance Level
  • ALBT $7.89
  • WTO $1.66
  • Average True Range (ATR)
  • ALBT 0.63
  • WTO 0.23
  • MACD
  • ALBT -0.19
  • WTO -0.05
  • Stochastic Oscillator
  • ALBT 8.59
  • WTO 6.15

Stock Price Comparison Chart: ALBT vs WTO

ALBT
WTO
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April051015202530354045505560ALBT VS WTO

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use